
### [NCIT:C94760](http://purl.obolibrary.org/obo/NCIT_C94760)
**Label:** Non-Functioning Endocrine Neoplasm

**Subclasses:** [NCIT:C45924](http://purl.obolibrary.org/obo/NCIT_C45924) (Null Cell Pituitary Gland Adenoma), [NCIT:C4348](http://purl.obolibrary.org/obo/NCIT_C4348) (Non-Functioning Pituitary Gland Adenoma), [NCIT:C45935](http://purl.obolibrary.org/obo/NCIT_C45935) (Pituitary Gland Oncocytic Adenoma), [NCIT:C45838](http://purl.obolibrary.org/obo/NCIT_C45838) (Non-Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C28333](http://purl.obolibrary.org/obo/NCIT_C28333) (Non-Functional Pancreatic Delta Cell Neuroendocrine Tumor), [NCIT:C4009](http://purl.obolibrary.org/obo/NCIT_C4009) (Non-Functioning Pituitary Gland Neoplasm), [NCIT:C45837](http://purl.obolibrary.org/obo/NCIT_C45837) (Non-Functional Pancreatic Neuroendocrine Tumor), [NCIT:C121721](http://purl.obolibrary.org/obo/NCIT_C121721) (Non-Functioning Pituitary Gland Macroadenoma), [NCIT:C48458](http://purl.obolibrary.org/obo/NCIT_C48458) (Non-Functioning Adrenal Cortex Adenoma), [NCIT:C95585](http://purl.obolibrary.org/obo/NCIT_C95585) (Non-Functional Pancreatic Neuroendocrine Tumor G1), [NCIT:C121678](http://purl.obolibrary.org/obo/NCIT_C121678) (Non-Functioning Pituitary Gland Microadenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C45980](http://purl.obolibrary.org/obo/NCIT_C45980) (Absence of a Hormonal Syndrome) 57.14%
- Thing 52.12%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 42.50%


